오정미, 고민오, 약물치료학: 최적의 임상약료서비스 제공을 위한 약물요법(제6개정). 제 1권. 11장 이상지질혈증
논문1
Park HJ*, Ko M*, Kim IW, Oh JM. Personalized risk assessment for taxane-induced hypersensitivity reactions: A systematic review and meta-analysis. J. Pers. Med. 2025, 15, 2.
논문2
Lee WV, Song Y, Chun JS, Ko M, Jang HY, Kim IW, Park S, Lee H, Lee HY, Kwak SH, Oh JM. Development of a machine learning model for precision prognosis of rapid kidney function decline in people with diabetes. Diabetes Research and Clinical Practice. 2024, 217, 111897.
논문3
Ko M, Kim HJ, Kim IW, Kim TM, Oh JM. Predictive Factors and Prognostic Relevance of Sunitinib-induced Subclinical and Overt Hypothyroidism in Korean Patients with Metastatic Renal Cell Carcinoma. Korean J Clin Pharm. 2024. 34(3):184-193.
논문4
Ko M, Kim S, Suh SY, Cho YS, Kim IW, Yoo SH, Lee JY, Oh JM. Consultation-based deprescribing service optimizing palliative care for terminal cancer patients. J. Clin. Med. 2023. 12(23), 7431.
논문5
Ko M, Kim MG, Yoon S-S, Kim I-W, Suh SY, Cho Y-S, Oh JM. Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia. Front. Nutr. 2023. 10:1122010.
논문6
Ko M, Oh JM, Kim I-W. Front. Med. Drug repositioning prediction for psoriasis using the adverse event reporting database. Front. Med. 2023. 10:1159453.
논문7
Ko M, Choi J, Kim S, Kim SH, Cho EJ, Cho YS, Koh YI, Oh JM. Real-world Data-based Adverse Drug Reactions Analysis of Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma. Journal of Pharmacoepidemiology and Risk Management 2022. 14:149-157.
논문8
Jeong S, Sohn M, Kim JH, Ko M, Seo HW, Song YK, Choi B, Han N, Na HS, Lee JG, Kim IW, Oh JM, Lee E. Current globalization of drug interventional clinical trials: characteristics and associated factors 2011-2013. Trials. 2017. 18(1):288.
논문9
Kim MG, Ko M, Kim I-W, Oh JM. Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference. Onco Targets Ther. 2016. 18;9:7133-7139.
